Protagonist Therapeutics set to join S&P SmallCap 600
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 28 2024
0mins
Source: SeekingAlpha
- Protagonist Therapeutics in S&P SmallCap 600: Protagonist Therapeutics will replace Encore Wire in the S&P SmallCap 600 before trading on July 3.
- Acquisition by Prysmian SpA: Prysmian SpA, an S&P Europe 350 constituent, is acquiring Encore Wire pending final conditions.
- S&P Global Inc. News: Various news related to S&P Global Inc., including business characteristics, CEO appointment, and data issues causing delays in pricing.
Analyst Views on SPGI
Wall Street analysts forecast SPGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPGI is 611.40 USD with a low forecast of 540.00 USD and a high forecast of 661.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 545.430
Low
540.00
Averages
611.40
High
661.00
Current: 545.430
Low
540.00
Averages
611.40
High
661.00
About SPGI
S&P Global Inc. provides essential intelligence. Its operations consist of five businesses: S&P Global Market Intelligence (Market Intelligence), S&P Global Ratings (Ratings), S&P Global Commodity Insights (Commodity Insights), S&P Global Mobility (Mobility) and S&P Dow Jones Indices (Indices). Market Intelligence is a global provider of multi-asset-class data and analytics integrated with purpose-built workflow solutions. Ratings is an independent provider of credit ratings, research, and analytics, offering investors and other market participants information, ratings and benchmarks. Commodity Insights is an independent provider of information and benchmark prices for the commodity and energy markets. Mobility is a provider of solutions serving the full automotive value chain, including vehicle manufacturers and retailers. Indices is a global index provider that maintains a variety of valuation and index benchmarks for investment advisors, wealth managers and institutional investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
